Turkish Validation of the Rapprich Lipedema Symptomatic Assessment Questionnaire
Recruiting
Observational Study
Lipedema
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 – 75
- Sex
- Female
- Study type
- Observational
- Participants needed
- 180 (estimated)
- Sponsor
- Marmara University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Lipedema is a chronic disease characterized by abnormal fat accumulation, primarily in the lower extremities, affecting women. This study aims to evaluate the validity and reliability of the Turkish version of the Rapprich Lipedema Symptomatic Assessment Questionnaire, which was originally developed by Rapprich et al. in 2010. Since a validated Turkish version is currently unavailable, this resear…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Female patients aged 18-75.
* Diagnosed with lipedema by a clinician.
* Willingness to participate and sign the informed consent form.
Exclusion Criteria:
* Positive Stemmer sign or presence of advanced-stage lymphedema.
* Diagnosis of Heart Failure.
* Chronic Kidney Disease…
Contacts
M. Selim Eryılmaz, Res. Asst.
CONTACT